Qure.ai

Mumbai, India Founded: 2016 • Age: 10 yrs Minicorn
AI-powered solutions for medical imaging diagnostics

About Qure.ai

Qure.ai is a Healthcare company based in Mumbai (India) founded in 2016 by Prashant Warier. AI-powered solutions for medical imaging diagnostics. It operates in the Healthcare and Technology sectors. Qure.ai has raised $122.66 million across 8 funding rounds from investors including Merck, Lightspeed Venture Partners and 360 One. The company has 227 employees. Qure.ai was last valued at $220.27 million in May 2024. Its chief executive, as recorded, is Prashant Warier. Its website qure.ai draws about 89 thousand monthly visits. Its Indian entity Qure.Ai Technologies Private Limited reported revenue of ₹190 Cr. Qure.ai offers products and services including qXR, qTrack, Chest X-ray Reporting, Lung Nodule Management, and Stroke & TBI. Its focus areas include HealthTech, Healthcare IT, Provider and Clinical Operations.

Company details

Qure.ai was founded in 2016 in Mumbai, India, within the healthcare technology sector. Operations center on AI-driven tools that support diagnostics through deep learning analysis of X-rays, CT scans, and MRIs. Early detection and management of tuberculosis, lung cancer, stroke, and COVID-19 are facilitated for healthcare professionals across various global settings.

  • Headquarters Mumbai, India
  • Employees 227
  • Founders Prashant Warier
  • Stage Minicorn
  • Sectors
    Healthcare
    Technology
  • Email
    ••••••••
  • Website qure.ai
  • Social LinkedIn X Facebook YouTube
  • Legal Name Qure.Ai Technologies Private Limited
  • Date of Incorporation 19 Jul, 2016
  • Jurisdiction Mumbai, Maharashtra, India
Key Metrics
  • Annual Revenue
    ₹190 Cr

    FY 2025 · +24% YoY

  • Net Loss
    -₹90.37 Cr

    FY 2025 · -47% margin

  • EBITDA
    -₹65.00 Cr

    FY 2025 · -34% margin

  • Total Equity Funding
    $122.66M (USD)

    in 8 rounds

  • Latest Funding Round
    $65M (USD), Series D

    Sep 2024

  • Investors
    Merck

    & 46 more

  • Employee Count
    227

Products & Services of Qure.ai

Qure.ai offers a comprehensive portfolio of products and services, including qXR, qTrack, Chest X-ray Reporting, Lung Nodule Management, and Stroke & TBI.

qXR
AI Imaging Tool

AI for analyzing chest X-rays to detect tuberculosis early.

qTrack
Reporting Platform

Platform for healthcare screening and case management programs.

Chest X-ray Reporting
Diagnostic Service

Tools to report and manage chest X-ray results for diseases.

Lung Nodule Management
Disease Monitoring

AI system for tracking lung nodules and disease progression.

Stroke & TBI
Care Coordination

AI suite for stroke triage and timely clinical interventions.

Apps and channels of Qure.ai

Qure.ai publishes 2 mobile apps with over 10.1K+ downloads; its YouTube channel Qure AI has 1K subscribers and 30 videos.

Qure.ai
Google Play Medical Everyone Free
Developer: Qure.ai Technologies Pvt Ltd
View on Google Play
Qure.ai App
Google Play Medical Everyone Free
Developer: Qure.ai Technologies Pvt Ltd
View on Google Play
Qure AI
YouTube 1K subscribers 30 videos Science & Technology
Open channel

Videos from Qure.ai

The most watched videos on Qure.ai's YouTube channel, Qure AI (1K subscribers). Click a video to play it here.

Introducing Aira– AI Co-pilot for Health Workers
861 views
AI on Top of the World | Qure.ai at Everest Base Camp
697 views
Breath of Hope: How AI is Transforming Tuberculosis Screening & Management in the Philippines
555 views
AI-powered Hub & Spoke Stroke Care Network
396 views

More on Qure AI.

Funding Insights of Qure.ai

Qure.ai has successfully raised a total of $122.66M across 8 strategic funding rounds. The most recent funding activity was a Series D round of $65 million completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $122.66M
  • Total Rounds 8
  • Last Round Series D — $65M
  • First Round $15.97M

    (Feb 2020)

  • Investors Count 47

All 8 funding rounds of Qure.ai with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Sep 2024$65MSeries D–360 One
May 2024$1.69MSeries C$220.27MMerck Global Health Innovation Fund
–
Jun 2023Grant––
Jun 2023Grant––
Apr 2022Series C$149.46MMerck, Merck Sharp & Dohme
–
Mar 2022$40MSeries C$•••••HealthQuad, Novo Holdings
Feb 2022$4.35MGrant––
Feb 2020$15.97MSeries B$•••••Pranay Agarwal, Peak XV Partners
Valuation history
DateValuationStage
May 2024$220.27M••••••••
Apr 2022$149.46M••••••••
Mar 2022$•••••••••••••
Feb 2020$•••••••••••••
Premium access

Full valuation and stage history of Qure.ai

Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.

  • All valuation points
  • Stage changes
  • Dates
  • Exports

Verified entity values are shown only after access is granted.

Last known valuation $220.27M (May 2024). 47 investors in total: 16 institutional and 31 angel.

Investors in Qure.ai

Qure.ai has secured backing from 47 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include Merck, Lightspeed Venture Partners and 360 One.

All
Venture Fund
Institutional
Angel
InvestorDescriptionFounded YearDomainLocation
Corporate-backed venture capital is focused on the life science sector.
merckghifund.comKenilworth, United States
Early-stage investing in tech startups in India.
2011kae-capital.comMumbai, India
Private equity and venture capital fund focused on the healthcare sector
novoholdings.dkHellerup, Denmark
Healthcare investment fund focused on innovation and social impact in India.
2016healthquad.inDelhi, India
Venture capital investing in innovative companies across global sectors is undertaken by Lightspeed Venture Partners.
1997lsvp.comMenlo Park, United States
Bioscience research, innovation, and entrepreneurship facilitation in life sciences are conducted in India.
2010ccamp.res.inBengaluru, India
Seed capital grants are provided to incubate and accelerate innovations.
2020actgrants.inBengaluru, India
Corporate-backed venture capital fund
massmutualventures.comBoston, United States
Venture capital firm investing in startups and providing support programs.
2000peakxv.comBengaluru, India
Asset and wealth management software is provided for businesses.
2008360.oneMumbai, India
Premium access

Investor details for Qure.ai

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Qure.Ai Technologies Private Limited (Qure.ai)

Qure.Ai Technologies Private Limited is the primary company behind Qure.ai. The board of Qure.Ai Technologies Private Limited currently have 7 directors; the longest-serving is Satish Avadhanam Raman, appointed in 2020. 17 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Satish Avadhanam Raman
DIN 07025389
Director28 Feb 20206 yrs 7 moQure.Ai Technologies Private Limited
Charles Antoine Janssen
DIN 01266976
Director13 Apr 20224 yrs 6 moQure.Ai Technologies Private Limited
Amit Kakar
DIN 03425585
Director13 Apr 20224 yrs 6 moQure.Ai Technologies Private Limited
Chintamani Aniruddha Bhagat
DIN 07282200
Director19 Jan 20233 yrs 9 moQure.Ai Technologies Private Limited
Prashant Warier
DIN 05340726
CEO01 Apr 20233 yrs 6 moQure.Ai Technologies Private Limited
Devtosh Kumar Khare
DIN 07168514
Director30 Oct 20241 yr 11 moQure.Ai Technologies Private Limited
Tarun Sharma
DIN 03095034
Nominee Director12 Dec 20241 yr 10 moQure.Ai Technologies Private Limited

People of Qure.ai

115 people are tracked at Qure.ai (51 in leadership, 8 in board & advisors, 56 in team); the tracked headcount is 227.

NameRoleGroup
Co-Founder & CEOLeadership
Anshul Chauhan
Director Of EngineeringLeadership
Amy Casey
Senior Vice PresidentLeadership
Dhruv Pandey
Vice President Of Business DevelopmentLeadership
Sahil Chanchad
Director Of EngineeringLeadership
Bhargava Reddy
Chief Business Officer, OncologyLeadership
Bunty Kundnani
Chief Regulatory Affairs OfficerLeadership
Poonam Ajgaonkar
Chief People OfficerLeadership
Surabhi Srivastava
VP, Business Development, UKLeadership
Sundar Thayappan
Associate Director - Product InnovationLeadership
Divya Gupta
Chief Business Officer, Global HealthLeadership
Saniya Pawar
Vice President, Operations - Operational Research And Impact MeasurementLeadership
Gangaprasad Koturwar
Vice President Of EngineeringLeadership
Paridhi Gupta
Associate DirectorLeadership
Shibu Vijayan
Chief Medical Officer, Global HealthLeadership
Ankit Modi
Chief Product OfficerLeadership
Anumeha Srivastava
Chief Business Officer, NeurologyLeadership
Abhijeet Sutar
VP Of EngineeringLeadership
Dhruv Shah
Director, ProductsLeadership
Jai Bassi
Senior Director, Global HealthLeadership

95 more people are available in the full profile.

Premium access

Complete people profiles for Qure.ai

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Qure.ai

Figures of Qure.Ai Technologies Private Limited, the primary company behind Qure.ai, for FY 2025. Revenue was ₹190 Cr (+24% year on year). Net loss was -₹90.37 Cr (-47% margin). EBITDA was -₹65.00 Cr (-34% margin). Revenue has grown at a compounded annual rate of +69% over three years and +170% over five years.

  • ₹190 CrRevenue · FY 2025 · +24% YoY
  • -₹90.37 CrNet loss · -47% margin
  • -₹65.00 CrEBITDA · -34% margin
  • ₹543 CrPaid-up capital
  • 227Employees (provident fund records)
  • +69%Revenue CAGR, 3 years
  • +170%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Qure.Ai Technologies Private Limited are on its company page.

Premium access

Detailed financial statements for Qure.ai

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Qure.ai

4 dated milestones of Qure.ai across 8 years, from founding to its latest funding, stage changes and deals.

  1. Founded Qure.ai is founded.
  2. Funding First funding round of $16.0M.
  3. Milestone Reaches Minicorn status.
  4. Funding Latest funding round, Series D, of $65.0M.

Web traffic of Qure.ai

The website of Qure.ai (qure.ai) receives about 89.4K visits a month.

  • Monthly visits
    89.4K

    ▲ 11.7% vs previous month

Similar websites

Websites whose visitors overlap most with Qure.ai. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
ai.google
100%
2.9M#29,193View details
proserveit.com
98%
35.3K#918,506View details
leetcode.com
92%
38.5M#1,101View details
deepai.org
90%
#7,271View details
oxipit.ai
89%
5.9K#3,241,246View details
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 40 similar websites and full traffic analytics for Qure.ai

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Qure.Ai

Premium access

Complete news archive for Qure.ai

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Qure.ai

Qure.ai was founded in 2016 and raised its 1st funding round 4 years after it was founded.

Qure.ai is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

Prashant Warier is the CEO of Qure.ai, as recorded in our data. They have also founded this company.

Qure.ai is a funded company, having raised a total of $122.66M across 8 funding rounds to date. The company's 1st funding round was a Series B of $15.97M, raised on Feb 2020.

Qure.ai has 227 employees.

The primary company behind Qure.ai, Qure.Ai Technologies Private Limited, reported revenue of ₹190 Cr for FY 2025, up 24% year on year.

Qure.ai was founded in 2016 in Mumbai, India, within the healthcare technology sector. Operations center on AI-driven tools that support diagnostics through deep learning analysis of X-rays, CT scans, and MRIs. Early detection and management of tuberculosis, lung cancer, stroke, and COVID-19 are facilitated for healthcare professionals across various global settings.

Qure.ai offers qXR, qTrack, Chest X-ray Reporting, Lung Nodule Management, and Stroke & TBI.

Qure.ai has 47 investors. Key investors include Merck, Lightspeed Venture Partners, 360 One, Kae Capital, and Peak XV Partners.

The valuation of Qure.ai is $220.27M as of May 2024.

Qure.ai operates through Qure.Ai Technologies Private Limited.

The legal entities of Qure.ai currently have 9 directors, including Charles Antoine Janssen, Prashant Warier, Satish Avadhanam Raman and others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available